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Brief Definitive Report

CD103+ pulmonary dendritic cells
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apoptotic cell–associated antigen
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Cells undergoing programmed cell death (apoptosis) are removed in situ by macrophages
and dendritic cells (DCs) through a specialized form of phagocytosis (efferocytosis). In the
lung, there are two primary DC subsets with the potential to migrate to the local lymph
nodes (LNs) and initiate adaptive immune responses. In this study, we show that only
CD103+ DCs were able to acquire and transport apoptotic cells to the draining LNs and
cross present apoptotic cell–associated antigen to CD8 T cells. In contrast, both the
CD11bhi and the CD103+ DCs were able to ingest and traffic latex beads or soluble antigen.
CD103+ DCs selectively exhibited high expression of TLR3, and ligation of this receptor led
to enhanced in vivo cytotoxic T cell responses to apoptotic cell–associated antigen. The
selective role for CD103+ DCs was confirmed in Batf3/ mice, which lack this DC subtype.
Our findings suggest that CD103+ DCs are the DC subset in the lung that captures and
presents apoptotic cell–associated antigen under homeostatic and inflammatory conditions
and raise the possibility for more focused immunological targeting to CD8 T cell responses.
CORRESPONDENCE
Claudia Jakubzick:
jakubzickc@njhealth.org
Abbreviations used: i.n.,
intranasal(ly); LLN, lung-draining
LN; mRNA, messenger RNA;
PBSE, Pacific blue succinimidyl
ester; PI, propidium iodide;
sOVA, soluble OVA.

Pulmonary DCs are the critical APCs that recognize and capture all types of antigens in the
lung. They then ferry and present these antigens in the lung-draining LN (LLN).These anti
gens include viruses, bacteria, fungi, and even
in the case of autoimmunity, self-antigens. Despite their essential roles, very little is known
about the basic mechanisms or selectivity by
which pulmonary DCs acquire pathogens or
host cells and how they subsequently regulate
the immune response.
Three DC types have been described in the
naive lung: plasmacytoid DCs and two migratory
DCs, CD103+ and CD11bhi DCs (Vermaelen
and Pauwels, 2004; Sung et al., 2006; Jakubzick
et al., 2008a). The functional roles of pulmonary DC subsets are beginning to unfold
(Plantinga et al., 2010). An in vitro study extracting LLN migratory DCs containing soluble
OVA (sOVA) suggested that pulmonary CD103+
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DCs could cross-present antigens on MHC
class I, whereas CD11bhi DCs were responsible
for antigen presentation on MHC class II (Belz
et al., 2007; del Rio et al., 2007). In vivo studies,
using deletion approaches and transcription
factor knockout mice for the depletion of
DC subsets, revealed that pulmonary CD103+
DCs are required for a CTL response to viruses
(GeurtsvanKessel et al., 2008; Kim and Braciale,
2009; Edelson et al., 2010). Yet it remains unclear how the DCs acquired the virus for presentation. DCs may take up virus directly or by
ingestion of an infected cell such as a dying
epithelial cell. Recognition and removal of
cells undergoing apoptosis and other forms of
© 2011 Desch et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after
the publication date (see http://www.rupress.org/terms). After six months it is
available under a Creative Commons License (Attribution–Noncommercial–Share
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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Figure 1. Apoptotic cell trafficking to the LLN by lung CD103+ DCs.
(A) C57BL/6 mice were inoculated i.n. with CFSE-labeled apoptotic thymocytes in the absence (top) or presence (bottom) of 2 µg LPS. Control mice
received no cells. LLN cells were isolated 24 h later and analyzed by flow
cytometry. Efferocytic cells were identified as CFSE+, and migratory DCs
were identified as CD11c+MHCIIhi. Overlays show CFSE+ cells (black) and
total live cells or total migratory DCs (yellow) as indicated. Numbers indicate frequency of CFSE+ DCs that express CD103. Representative data
of four independent experiments with three mice/group are shown.
(B) Skin-draining LNs (SLNs) and LLNs were sectioned 24 h after delivery
of CFSE-labeled apoptotic thymocytes. Tissue sections were stained with
anti-B220 (red) and CFSE (green). Bars, 40 µm. (C) 24 h after i.n. delivery
of CFSE-labeled apoptotic thymocytes, the frequency of CD103+ DCs
among total CFSE+ cells was calculated in the LLN during the indicated
times throughout an acute inflammatory response. As a control, PKH 26
cell-free tracer was used to track migratory DCs to the LLN. Data represent the results of three independent experiments. (D) C57BL/6 mice were
inoculated i.n. with CFSE-labeled apoptotic BALB/c thymocytes, human
1790

RESULTS AND DISCUSSION
CD103+ DCs but not CD11bhi DCs selectively traffic
apoptotic cells to the draining LN
Intranasal (i.n.) delivery of CFSE-labeled apoptotic thymocytes showed that of the migratory DCs in the draining LNs,
only CD103+ DCs captured apoptotic cells (Fig. 1 A). This
was true whether or not LPS was included in the instillate to
enhance DC migration (Jakubzick et al., 2008a). Furthermore, essentially all the CFSE+ cells were located within the
CD103+CD11c+MHCIIhi migratory DC population assessed
by FACS, and nearly all efferocytic cells were localized to the
T cell zone of the LLN by immunohistochemistry (Fig. 1,
A and B). This selectivity was striking because our previous
study showed that bead particles, soluble protein, and free
CFSE delivered i.n. are trafficked to the LLN by both pulmonary CD103+ and CD11bhi DCs (Jakubzick et al., 2008a).
Importantly, apoptotic cells in the lung, for example during resolution of inflammation, can be taken up by alveolar macrophages

neutrophils, or murine lung epithelial cell line (MLE 12). Uptake by migratory DCs was accessed 24 h later. (C and D) Each dot represents an individual mouse. Bars represent the mean of the individual mice per group.
Efferocytic pulmonary dendritic cells | Desch et al.
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programmed cell death occur by specific recognition of ligands and uptake processes termed efferocytosis (deCathelineau
and Henson, 2003), a property which is shared by macrophages and some subsets of DCs.Thus, within the splenic DC
populations, CD8+ DCs selectively acquire apoptotic cells.
This selectivity was also observed in nonlymphoid DC subsets in mouse liver and rat intestine (Iyoda et al., 2002; Qiu
et al., 2009); however, the expression of CD103 was not investigated. Moreover, there is indirect evidence that CD103+
DCs in the skin capture self-apoptotic cells during homeo
stasis (Bedoui et al., 2009). CD103+ DCs, including pulmonary CD103+ DCs, share many similar properties with the
lymphoid CD8+ DCs of the spleen, including developmental
regulation by Flt3 and transcription factors Irf8 and Batf3
(Edelson et al., 2010), and the capacity to cross-present antigen.
However, besides their differences in location, there is one
property they do not share, which is the capacity to migrate
down afferent lymphatics (Smith and Fazekas de St Groth,
1999). The finding that not all DCs migrate to the draining
LN when injected into nonlymphoid sites such as the skin
further supports the need to understand the functional roles
of tissue-resident DCs.
Accordingly, to delineate functional roles of the different
pulmonary DCs, we set out to identify which migratory DC
population was capable of acquiring apoptotic cells in the tissue for presentation of contained antigen in the LLN. We
hypothesized and now show that pulmonary CD103+ DCs
selectively express TLR3 and exhibit preferential uptake and
trafficking of apoptotic cells compared with the CD11bhi
DCs. Furthermore, only the CD103+ migratory DCs were
capable of cross-presenting airway apoptotic cell–associated
antigen in the LLN.

Br ief Definitive Repor t

Figure 2. CD103+ DCs preferentially take up apoptotic cells,
whereas both CD103+ and CD11bhi cells take up particulate beads.
(A) C57BL/6 mice were inoculated i.n. with 30 × 106 latex beads of the
indicated size, and the total number of bead+ cells (top) or frequency of
CD103+ DC among all bead+ cells (bottom) was determined 24 h later. NA
indicates not quantitated because of the paucity of migrated beads. Data
shown are representative of three independent experiments. Mean ± SEM
is shown. (B) C57BL/6 mice were inoculated i.n. with 30 × 106 latex beads
(1 µm) or OVA-FITC, and 24 h later, LLN bead+ or OVA-FITC+ migratory DCs
were analyzed by flow cytometry. (C) LLNs were harvested from mice
inoculated with beads alone (top), CFSE-labeled apoptotic cells (middle),
and beads with CFSE-labeled apoptotic cells (bottom). LLNs were gated on
JEM Vol. 208, No. 9

bead+ cells (blue), CSFE+ cells (yellow), or CSFE+bead+ cells (green). Histograms show CD103 expression on gated cells (CD103lo = CD11bhi DCs;
CD103hi = CD103+ DCs). Data are representative of two independent experiments with three mice/group. (D) Lung tissue was harvested 2 h after
i.n. inoculation with CFSE-labeled apoptotic cells, and the frequency of
the indicated DC subsets was determined by flow cytometry. Data are
representative of three independent experiments. Error bars indicate SEM.
(E) CD103+ or CD8+ DCs were isolated from lungs (top) and spleen (middle) and cultured with PBSE-labeled apoptotic cells for 4 h. The frequency
of apoptotic cell uptake for each population among total PBSE+ DCs was
calculated (bottom). Each dot represents the mean of triplicates from
three independent experiments. Error bars indicate SEM.
1791

Downloaded from https://rupress.org/jem/article-pdf/208/9/1789/539150/jem_20110538.pdf by Washington University In St. Louis Libraries user on 16 December 2019

as well as by DCs, a competitive effect which required administration of large enough numbers of apoptotic cells to overcome this potential competition.
It was possible that CD11bhi DCs might gain the property
of efferocytosis during an acute inflammatory response, either
from the change in milieu and/or because a quantitative advantage exists for CD11bhi DCs when they preferentially accumulate in the lung during inflammation (Kirby et al., 2006;
GeurtsvanKessel et al., 2008, 2009; Kim and Braciale, 2009;
Lukens et al., 2009; Ballesteros-Tato et al., 2010). Accordingly,
inflammation was induced by i.n. delivery of 2 µg LPS 6, 3, 2,
or 1 d before delivery of CFSE-labeled apoptotic cells. 24 h
after apoptotic cell delivery, DCs were analyzed for uptake
and trafficking of CFSE+ apoptotic cells to the LLN. However, regardless of the time apoptotic cells were introduced
within an acute inflammatory environment, CD103+ DCs
were consistently found to preferentially transport apoptotic
cells to the LLN (Fig. 1 C). Therefore, even in the context of
acute inflammation where epithelial permeability is enhanced,
CD11bhi DCs do not contribute substantially to the trafficking of apoptotic cells to the LLN.
To ascertain whether the acquisition and trafficking of
apoptotic cells by CD103+ DCs was conserved using different apoptotic cell sources, C57BL/6 mice were given CFSElabeled apoptotic BALB/c thymocytes, human neutrophils, or
murine lung epithelial cells and analyzed for CFSE+ migratory DCs in the LLN 24 h later. Even when mouse strains and
species were incongruent, pulmonary CD103+ DCs still maintained their selectivity for the transport of apoptotic cells to
the LLN (Fig. 1 D and Fig. S1). Overall, these data demonstrate that CD103+ DCs are efferocytic.
CD103+ DCs preferentially localize along the airways and
line the vasculature (Sung et al., 2006). Because there might
be a locational advantage that allows CD103+ DCs to acquire
apoptotic cells, co-delivery of particulate beads and apoptotic
cells was examined. Initial experiments assessed the uptake
and trafficking of 1-, 2-, 3-, and 4.5-µm diameter latex beads
administered along with LPS to enhance DC migration and
allow detection of larger size beads in the draining LN
(Jakubzick et al., 2008a). As expected, both migratory pulmonary DC subsets transported the beads to the draining LNs;
however, the frequency of bead-positive CD103+ DCs slightly
increased as bead size increased (Fig. 2 A). Unlike apoptotic

Selective uptake of apoptotic cells by CD103+ DCs
in the lung tissue
To determine whether the selectivity for apoptotic cell trafficking to the LLN occurred at the level of recognition and
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uptake by DCs in the lung, lungs were harvested, and DCs
were sorted 2 h after i.n. delivery of the tagged apoptotic cells.
By immunofluorescence analysis, 30% of total lung CD103+
DCs had associated apoptotic cell bodies compared with 7%
of CD11bhi DCs (Fig. 2 D). The observation that after isolation from the lung, a few CD11bhi CD11chiMHCIIhi cells
contained apoptotic cells after cell sorting, whereas in the
draining LN only CD103+ DCs contained apoptotic cells,
suggests a possible explanation that CD11bhiCD11chiMHCIIhi
DCs represent a heterogeneous population containing other
monocytic-like cells, not yet identified, that can bind and/or
ingest apoptotic cell bodies, which are unable to migrate to
the LLN.
Moreover, in vitro uptake of apoptotic cells by pulmonary
DCs was assessed. In culture, pulmonary CD103+ DCs preferentially acquired apoptotic cells over CD11bhi DCs, albeit
with less efficiency than splenic CD8+ DCs (Fig. 2 E). Putting
the data together, we demonstrated that at the level of the
lung parenchyma, CD103+ DCs appear selectively specialized
to engulf apoptotic cells and subsequently transport these to
the LLN.
CD103+ DCs cross-present apoptotic cell–associated antigen
Pulmonary CD103+ DCs have been directly shown in vitro to be
specialized in cross-presentation (Belz et al., 2007; del Rio et al.,
2007). Because we have demonstrated in vivo a selective uptake
of apoptotic cells by CD103+ DCs, the selective ability of these
cells to cross present
antigen in vivo was
next examined using Figure 3. Efferocytic pulmonary CD103+
apoptotic thymocytes DCs are required for apoptotic cell acquisition, migration to the LLN, and crosspresentation. (A) Lung DC subsets from WT and
Batf3/ mice were gated on CD11c+ and analyzed by flow cytometry for expression of
MHCII, CD11b, and CD103. Cell were gated on
MHCII+ (left) and SiglecF (middle) and plotted
for CD11b and CD103 expression (right).
(B) LLNs were isolated from WT and Batf3/
mice 24 h after inoculation with CFSE-labeled
apoptotic cells. Cells were gated on live cells and
analyzed for CD11c versus CD11b (top) or
MHCII (bottom). Overlay plots show CFSE+ DCs
(black) and all migratory DCs (gray). Data are
representative of two independent experiments
with three mice/group. (C) WT and Batf3/
mice were inoculated with a 1:1 mixture of
CFSE-labeled OT-1 and OT-2 cells (2 × 106 total
cells) 1 d before i.n. delivery of apoptotic WT
cells, PBS, apoptotic OVA-expressing cells, or
1 μg sOVA. T cell proliferation was assessed 3 d
later. Data are representative of three independent experiments with two to three mice/
group. (D) DC subsets were isolated from PBSperfused lung tissue, and mRNA was isolated
for microarray analysis. Plots show fold change
of the indicated genes in pulmonary CD103+
DCs versus CD11bhi DCs (top) or pulmonary
CD11bhi DCs versus CD103+ DCs (bottom).

Efferocytic pulmonary dendritic cells | Desch et al.
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cells, beads are not malleable, therefore it may not be surprising that beads as large as 7-µm cells were not transported to
the LLNs. Detectable DC transport of beads was limited to
3-µm beads or smaller, as very few bead-carrying cells were
found in LNs when ≥4.5-µm particles were instilled. Most
notably, with 0.5- and 1-µm beads, CD103+ DCs not only
trafficked beads at a greater frequency, but also quantitatively
carried more beads per cell than CD11bhi DCs (Fig. 2 B and
not depicted for 0.5 µm). The same quantitative observation
was made for sOVA protein. That is, even though we have
previously shown that CD11bhi DCs traffic sOVA at a higher
frequency than CD103+ DCs (Jakubzick et al., 2008a), some
CD103+ DCs have quantitatively more OVA per cell than
CD11bhi DCs (Fig. 2 B). Thus, in general, CD103+ DCs appear
to be more endocytic than CD11bhi DCs. Because 3-µm beads
were the limiting bead size for DC trafficking, 2-µm beads
were chosen for co-delivery experiments with apoptotic cells.
Co-delivery of apoptotic cells i.n. along with 2-µm latex
beads revealed that CD103+ DCs either trafficked apoptotic
cells alone or apoptotic cells with beads to the LLN. In contrast, CD11bhi DCs carried beads but not apoptotic cells to
the LLN (Fig. 2 C). Because these data show that nonspecific
airway particulates can be engulfed and transported by
CD11bhi DCs as well as CD103+ DCs to the LLN, the specificity of the CD103+ DCs in efferocytosis was not caused by
failure of CD11bhi DCs to access phagocytic cargo.

Br ief Definitive Repor t

Cell-associated antigen presentation by CD103+ DCs
along with TLR3 agonist enhances IFN- production
and cytotoxicity from the proliferating OT-1 T cells
Unlike CD11bhi DCs, CD103+ DCs demonstrated selective
expression of TLR3, along with CCR9, CXCR3, XCR1,
and Cadm1 (Fig. 4 A and Table S1). In contrast, CD11bhi DCs
expressed Clec4a1, TLR2, and TLR7 (Fig. 4 A and Table S1).
JEM Vol. 208, No. 9

The data suggest a differential ability of the DC types to recognize and respond to pathogens.
TLR3 recognizes viral double-stranded RNA and is specifically expressed by CD103+ DCs. Therefore, we examined
the ability of Poly I:C, a TLR3 agonist, to enhance IFN-
production in proliferating OT-1 T cells after apoptotic cell–
associated antigen and soluble antigen presentation. Mice
treated with Poly I:C and OVA apoptotic cells did not promote

Figure 4. CD103+ DCs selectively express TLR3, which promotes
IFN- production and CTL responses. (A) Expression of the indicated
genes in pulmonary CD103+ DCs versus CD11bhi DCs (top) and pulmonary
CD11bhi DCs versus CD103+ DCs (bottom). (B and C) WT (B) and Batf3/ (C)
mice were inoculated with a 1:1 mixture of CFSE-labeled OT-1 and OT-2
cells (2 × 106 total cells) 1 d before i.n. delivery of apoptotic OVA ± 10 µg
Poly I:C (B) and apoptotic WT or OVA-expressing cells or sOVA ± 10 µg Poly
I:C (C). 3 d later, the cells were assessed for proliferation (B) or IFN-g production (C). Data are representative of two independent experiments. Error
bars indicate SEM. (D) OT-1 cells (1 × 106 total cells) were transferred into
WT mice 1 d before inoculation with WT or OVA-expressing apoptotic
cells ± 10 μg Poly I:C. 5 d later, mice were injected with a 1:1 ratio of CFSElolabeled WT and CFSEhi-labeled OVA+ splenocytes. The presence of CFSElo and
CFSEhi cells was assessed by flow cytometry 24 h later. Data are representative of two independent experiments with three mice/group. (E) Expression
of the indicated genes in pulmonary CD103+ DCs versus CD11bhi DCs (top).
Protein expression of CD36 and Clec9a (black line) on the indicated pulmonary DC subsets was analyzed by flow cytometry. Isotype control is indicated by the gray line. Gene expression analysis was performed on DC
populations isolated independently on three separate days.
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isolated from OVA-expressing mice (OVA apoptotic thymocytes). To examine the CD103+ DC specificity for crosspresentation of cell-associated antigen, Batf3/ mice were
used. Batf3/ mice lack lymphoid CD8+ DCs and nonlymphoid CD103+ DC in multiple tissues including the
lung and LLN (Fig. 3, A and B; Hildner et al., 2008; Edelson
et al., 2010). As shown in Fig. 3 B, the lack of CD103+ DCs and
trafficked CFSE-labeled apoptotic cells in LLN in the Batf3/
mice confirmed the requirement for this DC type.
Next, apoptotic cell–associated antigen presentation was
assessed by CD103+ DCs. Mice were given i.v. a 1:1 ratio of
CFSE-labeled OVA-specific OT-1 (CD8) and OT-2 (CD4)
transgenic T cells 1 d before i.n. delivery of OVA-apoptotic
thymocytes or sOVA. 3 d later, proliferation of OVA-specific
T cells was measured. Strikingly, antigen from OVA apoptotic
thymocytes was presented exclusively to CD8 T cells (Fig. 3 C).
In contrast, instillation of sOVA induced both OT-1 and OT-2
proliferation, i.e., both pulmonary DCs acquired and presented the antigen (Figs. 2 B and 3 C; Jakubzick et al., 2008a).
Thus, only the pulmonary CD103+ DC acquired and trafficked apoptotic cell–associated antigen and led to its crosspresentation to antigen-specific CD8 T cells. Unlike WT
mice, presentation of apoptotic cell–associated antigen to
either OT-1 or OT-2 T cells did not occur in Batf3/ mice
(Fig. 3 C), further confirming the role for CD103+ DCs.
However, this experiment does not exclude a possible role for
lymphoid CD8+ DCs (also absent in the Batf3/ mice) for
antigen presentation after CD103+ DCs transport antigen and
arrive in the draining LN (Belz et al., 2004). Delivery of sOVA
led to a skewed proliferative response of OT-2 T cells in the
Batf3/ mice compared with WT mice, whereas in the WT
mice the OT-1 T cell response was stronger, which is most
likely attributable to the enhanced antigen trafficking and
cross-presentation by the CD103+ DCs (Fig. 3 C).
Because pulmonary CD103+ DCs, along with splenic
CD8+ DCs, favor apoptotic cell uptake and cross-presentation,
we examined levels of gene expression in the MHC class I
and MHC class II pathway molecules in the former, as previously reported for splenic DCs (Dudziak et al., 2007). Indeed,
pulmonary CD103+ DCs demonstrated enhanced gene expression for MHC class I pathway molecules, whereas
CD11bhi DCs displayed enhanced expression in several of the
MHC class II pathway molecules (Fig. 3 D). The observation
supports the suggested intrinsic capacity of CD103+ DCs to
cross-present antigen, whereas CD11bhi DCs appear more
effective at presentation via MHC class II. However, these find
ings do not negate the ability for both pulmonary DCs to use
all of the antigen-presenting pathways.
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organ-specific vaccines, perhaps targeting tissue-resident DCs
might prove to be more efficacious.
It was unexpected that CD11bhi DCs under the conditions
studied would neither acquire nor traffic apoptotic cells to the
LLN because unlike splenic CD8 DCs, CD11bhi DCs arise
from the monocytic linage that gives rise to macrophages
(Landsman et al., 2007; Jakubzick et al., 2008b; Ginhoux et al.,
2009).Therefore, there appears to be a dichotomy between the
monocytic DC and macrophage, in which macrophages efferocytose with greater efficiency than pulmonary CD11bhi DCs.
Even though CD11bhi DCs do not appear to contribute substantially to airway apoptotic cell clearance, this finding does not
negate the possibility that CD11bhi DCs could acquire apoptotic or necrotic cells, or cellular contents, during an infection
where some studies have demonstrated that in the LLN CD11bhi
DCs in vitro can cross-present flu antigens (GeurtsvanKessel
et al., 2009; Kim and Braciale, 2009; Ballesteros-Tato et al.,
2010). Influenza is a lytic virus providing CD11bhi DCs with
free virions and necrotic cell debris. Alternatively, CD11bhi DCs
could be cross-dressed because a recent study demonstrated
that splenic CD8 DCs were more efficiently cross-dressed
than CD8+ DCs (Wakim and Bevan, 2011).
In conclusion, we demonstrate a major functional dif
ference between the two pulmonary DC subsets, a selective
skewing of apoptotic cell uptake by CD103+ DCs, and sub
sequent cross-presentation of associated antigen. Lack of the
CD103+ DCs in the Batf3/ mice prevented cross-presentation.
These experiments suggest that a major determinant in
this selectivity resides in the initial recognition and uptake of
the apoptotic cells by DC subsets within the lung parenchyma.
There are a host of potential receptors for apoptotic cell ligands that have been identified on phagocytes, including DCs,
and future studies will need to identify these on the different
DC subsets. Examination of the microarray screen of CD103+
versus CD11bhi DCs showed increased levels of messenger
RNA (mRNA) for candidates such as CD36, DEC205,TIM1, TIM-3, TIM-4, and Clec9a. CD36 and Clec9a were confirmed by cell surface protein levels (Fig. 4 E and Table S1),
which may provide a starting point for such investigation.
Accordingly, pulmonary CD103+ DCs are an attractive
DC subtype to exploit in strategies to potentiate peripheral tolerance, or antiviral and antitumor immunity, given their intrinsic ability to engulf apoptotic cells, migrate to LNs, cross-present
cellular antigen, and, with Poly I:C, promote cytotoxicity.
MATERIALS AND METHODS
Mice. CD45.1 and CD45.2 C57BL/6, 129/BL6 F2 (control for Batf3/
mice) OT-1, OT-2, CX3CR1gfp/gfp, and C57BL/6-Tg(ACTB-OVA)916Jen/J
mice were purchased from Jackson ImmunoResearch Laboratories, Inc.
Batf3/ mice were provided by K. Murphy. Mice were used for experiments
at 7–8 wk of age, housed in a specific pathogen-free environment at National
Jewish Health, and used in accordance with protocols approved by the Institutional Animal Care and Utilization Committee.
Flow cytometry. Single-cell suspensions were obtained from whole lung,
spleen, and LLN. All LLN data were individually harvested, not pooled, and
analyzed. Prior to lung extraction, mice were perfused with 10 ml PBS.
Efferocytic pulmonary dendritic cells | Desch et al.
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MHCII cell–associated antigen presentation (Fig. 4 B)
but instead induced three times more IFN-–producing
OT-1 T cells compared with mice treated with OVA apoptotic cells alone (Fig. 4 C). sOVA in the presence of Poly I:C
showed six times more IFN-–producing OT-1 T cells compared with mice given sOVA alone (Fig. 4 C). In contrast, this
enhancement was not observed in the Batf3/ mice, i.e.,
lacking the TLR3-expressing CD103+ DCs (Fig. 4 C).Thus,
these data suggest that Poly I:C–induced IFN- production
by antigen-specific CD8 T cells required the presence and
antigen presentation of CD103+ DCs.
This evidence of CD8 T cell activation suggests a comparable induction of cytotoxicity in the proliferating OT-1 T cells.
To examine this, OT-1 T cells were adoptively transferred into
mice 1 d before i.n. delivery of WT apoptotic thymocytes (as
control) or OVA apoptotic thymocytes with PBS or with 10 µg
Poly I:C. 5 d later, WT splenocytes and OVA-expressing
splenocytes were labeled with a low and high concentration of
CFSE, respectively, and then delivered i.v. at a 1:1 ratio as targets
for the measurement of antigen-specific cytotoxicity. 24 h after
splenic cell delivery, mice were assessed for their cytotoxic response to OVA-expressing splenocytes. Mice treated with WT
apoptotic thymocytes displayed equal ratios of WT and OVAexpressing splenocytes (Fig. 4 D). Mice treated with OVA apoptotic thymocytes alone displayed slight cytotoxicity toward the
OVA-expressing splenocytes. In contrast, there was almost complete ablation of OVA-expressing splenocytes in mice treated
with OVA apoptotic thymocytes and Poly I:C (Fig. 4 D). These
data demonstrated that the addition of Poly I:C with apoptotic
cells enhanced the cytotoxicity of antigen-specific T cells.
Overall, pulmonary CD103+ DCs and splenic CD8+
DCs share multiple attributes including growth factors and
transcription factors that regulate them, chemokine and pattern
recognition receptor expression, and functional proper
ties such as preferential uptake of apoptotic cells and crosspresentation. However, there is one major functional difference
between the nonlymphoid and lymphoid DCs: CD103+ DCs
migrate down afferent lymphatics, whereas CD8+ DCs do
not (Fig. S2 A; Smith and Fazekas de St Groth, 1999).There is
a study that has shown that peptide-pulsed CD8+ and CD8
splenic DCs elicit opposing immune responses (MaldonadoLópez et al., 1999). Because we and others show that splenic
CD8+ DCs do not migrate down afferent lymphatics, the
immunological outcome observed by the delivery of peptidepulsed splenic CD8+ DCs may have been caused by the
acquisition of dying CD8+ DCs by endogenous skin efferocytic DCs that cross-present in the draining LN (Bedoui
et al., 2009). In contrast, CD8 DCs, either CX3CR1hi or
CX3CR1lo (Fig. S2 B), do migrate to draining LNs to present
the peptide-pulsed antigen, leading to the immunological outcome observed (Smith and Fazekas de St Groth, 1999). The
inability of splenic CD8+ DCs to migrate should caution the
use of its human DC orthologue; for instance, if human blood
CD141+ DCs were antigen pulsed and adoptively transferred
into the dermis of patients, their lymphatic migratory capacity
would need to be investigated. Alternatively, when designing
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Immunostaining. Frozen sections of the LLN and skin brachial-LN were
fixed in 4% paraformaldehyde and stained with Cy5-B220 (eBioscience) or
isotype-matched control antibody.
i.n. deliveries. Administration of i.n. deliveries was performed using an
optimized delivery system previously described (Jakubzick et al., 2008a;
Jakubzick and Randolph, 2010). In brief, mice were completely anesthetized with Avertin using 300 µl per mouse with tert-amyl alcohol content at
2.5% and 2,2,2 tribromoethanol (T1420; TCI America) at a concentration
of 50 mg/kg. Cells or beads were diluted in PBS, and 50 µl of solution was
delivered i.n. Final concentration of deliveries were 20 × 106 apoptotic cells ±2 µg
LPS (Sigma-Aldrich), ±10 µg Poly I:C (InvivoGen), 1 µg sOVA (SigmaAldrich), and 30 × 106 of 0.5-, 1-, 2-, 3-, and 4.5-µm yellow-green carboxyl
ated beads (Polysciences). In co-delivery experiments, 20 × 106 apoptotic
cells and 30 × 106 2-µm beads were administered i.n. Mice were sacrificed
at various times dependent on experimental design.
Apoptotic cell delivery. Thymocytes were obtained from C57BL/6 and
BALB/c mice 7–8 wk of age. Single-cell suspensions were made using the
rubber end of a syringe and mashing cells through a 40-µm nylon filter.
Apoptosis of murine thymocytes and murine lung epithelial cells (MLE 12;
American Type Culture Collection) was induced by 60 mJ UV radiation exposure (StrataLinker 1800;Agilent Technologies) followed by 2-h (for thymo
cytes) and 3-h (for epithelial cells) incubation at 37°C in RPMI + 10%
FCS. Apoptosis of human neutrophils was induced by aging the cells overnight at 5 × 106 cells/ml in RPMI + 10% FBS at 37°C in 5% CO2 in a
25-cm2 TC flask (Frasch et al., 2011). Phosphatidylserine exposure was detected by Annexin V staining and propidium iodide (PI) to assure that no necrotic cells were present before delivery. 2 h (for thymocytes) or 3 h (for
epithelial cells) after UV exposure, cells were 60% apoptotic Annexin V+ PI,
40% were Annexin V PI (but with time these cells would all become apoptotic), and <0.2% were PI+. Apoptotic cells were labeled with 10 µM CFSE
(Invitrogen) and then resuspended and washed three times in 30 ml RPMI +
10% FCS before delivery.
Proliferation of OVA-specific transgenic CD8+ and CD4+ T cells.
Spleen cells from OT-1 and OT-2 mice, in which the TCR of CD8+ and
CD4+ cells are restricted to OVA were isolated and labeled with 10 µM
CFSE. Half a million of these cells were transferred i.v. into recipient mice
1 d before i.n. delivery of apoptotic cells and sOVA. Mice were sacrificed 3 d
after i.n. deliveries for analysis of T cell proliferation (CFSE dye dilution) in
the LLN and intracellular cytokine staining.
Intracellular cytokine staining. LLNs isolated 3 d after i.n. deliveries of
apoptotic cells or sOVA ± Poly I:C were teased and digested in Collagenase D
for 30 min and then pressed through a 100-µm nylon filter to obtain single-cell
suspensions of APCs and proliferating T cells. Isolated cells were cultured
JEM Vol. 208, No. 9

for 5 h in RPMI + 10% FCS containing 10 µM OVA257–264 and 10 µM
OVA323–339 and 10 µg/ml Brefeldin A. After surface staining, cells were fixed
in 4% paraformaldehyde and then blocked and permeabilized with PBSsaponin/milk. Cells were stained with APC conjugated to IFN- or isotype
control (BD).
In vivo cytotoxic T cell assay. 1 d after OT-1 cell adoptive transfer, WT
mice were administered by i.n. delivery with WT apoptotic or OVA apoptotic cells ± 10 µg Poly I:C. 6 d after immunization, labeled WT and OVA
splenocytes were injected i.v.WT spleen cells were labeled with 1 µM CFSE,
and spleen cells from actin-OVA+ mice were labeled with 10 µM CFSE. Labeled splenocytes were mixed in a 1:1 ratio before i.v. delivery of 107 cells/
mouse. The next day, spleens were harvested to acquire single-cell suspensions, and specific killing of adoptively transferred CFSE+ low and high populations was assessed by flow cytometry.
Microscopy. Pulmonary DC subsets were FACS sorted (MoFlo; Beckman
Coulter) from whole lung digests 2 h after CFSE-labeled apoptotic thymocytes were delivered i.n. Sorted DCs were stained with Image-iT LIVE
plasma membrane and nuclear labeling kit (Invitrogen), and then cytospins
were performed to deposit cells on positively charged glass slides. Images
were obtained using an AxioVision microscope (Carl Zeiss), and efferocytic
DCs were quantified using AxioVision digital imaging software (Carl Zeiss).
DCs were considered efferocytic if CFSE+ vesicles were detected within the
cellular membrane. To determine the percentage of CFSE+ DCs, 30–60 cells
were counted in 25 randomized fields of view per sample.
Isolation of splenic and lung DCs for in vitro analysis. From singlecell suspensions, isolation of CD45.2 splenic and lung DCs was performed
using CD11c microbeads from Miltenyi Biotec. Miltenyi Biotec instruction
for CD11c cell isolation was carefully followed. Triplicates of 1 × 105 DCs
were cultured in 96-well flat-bottom plates in RPMI + 5% FCS, 50 µM
mercaptoethanol, l-glutamine, streptomycin, and penicillin and allowed to
rest for 1 h. After 1 h, Pacific blue succinimidyl ester (PBSE; Invitrogen)–
labeled CD45.1 apoptotic thymocytes were cultured for 4 h at 37°C. After
incubation, cells were harvested and stained for DC subsets from the lung and
spleen. A final concentration of 1 mM EDTA was added to promote nonadherence of apoptotic cells on DCs. In addition, analysis to exclude externally
adhered apoptotic cells on DCs was performed by excluding DCs expres
sing CD45.1.
In vivo analysis of splenic DC migration CD45.2 splenic DC subsets
were sorted using the BD Aria. Intradermal injections of splenic DCs were
placed into the back skin of CD45.1 mice. 24 h after injection, skin-draining
LNs were harvested, digested, and analyzed for DC migration. From singlecell suspensions of CD45.2 CX3CR1gfp/gfg mice, isolation of the CD45.2
splenic DCs was performed using CD11b microbeads from Miltenyi Bio
tec, followed by sorting GFPhi and GFPlo DC–expressing subsets using the
BD Aria.
Gene array. Whole-mouse genome Affymetrix gene arrays were performed
with the Immunological Genome Project (ImmGen) at Harvard University
(Heng and Painter, 2008). As per the specifications of ImmGen, we followed
a standard operation procedure for the isolation and purification of all cell
populations that is uniform across the ImmGen dataset. Procedures for cell
isolation, sorting, and RNA extractions are outlined in extensive detail at
http://www.immgen.org. Briefly, PBS-perfused lungs and spleens were digested using 1.75 mg/ml Liberase Blendzyme 3 (Roche) for 15 min, filtered
twice through a 100-µm nylon strainer, washed with HBSS, and then stained
with conjugated flow cytometry antibodies (eBioscience) to identify pulmonary DCs, pulmonary macrophages, splenic DCs, and splenic T cells. PI was
used to exclude dead cells. Cell populations were sorted twice to enhance
purity (BD Aria). The entire procedure from the time of sacrifice to cells
collected in TRIZOL was completed in <3 h, which is a requirement by
ImmGen. Flow plots of the actual sorts and cells used for RNA extraction
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All tissues were minced and then digested with 2.5 mg/ml collagenase D
(Roche) for 30 min at 37°C. 100 µl of 100 mM EDTA was added to stop
the digestion, and then the tissue was collected using a glass Pasteur pipette
and pressed through a 100-µm nylon strainer for single-cell suspension.
Spleens were treated with 7.5 ml of ammonium chloride lysing reagent
(BD), followed rapidly by the addition of 7.5 ml HBSS. Cells were resuspended in FACS blocking solution and stained for 30 min with conjugated
antibodies obtained from eBioscience and BD.The following purified mAbs
were used for staining: Pacific blue–conjugated mAbs to CD8 and I-A/I-E;
PE-conjugated mAbs to I-A/I-E, Siglec F, CD11b, CD8, or CD103; PerCPCy5.5–conjugated mAbs to CD4 or CD11b; PE-Cy7–conjugated mAb to
CD11c; and allophycocyanin-conjugated mAbs to CD103. CD36 was purchased from BioLegend, and biotin-conjugated mAb to Clec9a was provided by M.H. Lahoud, I. Caminschi, and K. Shortman (Caminschi et al.,
2008). Appropriate isotype-matched control mAbs were also obtained from
eBioscience, BD, and BioLegend. Flow cytometry was performed using the
LSR II (BD), and data were analyzed with FlowJo (Tree Star).

may be viewed at http://www.immen.org. All datasets have been deposited
in GEO DataSets under accession no. GSE15907. Validation for the use of
pulmonary DC gene arrays was assessed by the confirmation of mRNA expression for known surface proteins, transcription factors, and growth factors
associated with pulmonary DCs and controls to compare with splenic DCs,
pulmonary macrophages, and splenic CD4 T cells (Table S2).

Online supplemental material. Fig. S1 displays the gating strategy for
CFSE+ DCs in the LLN 24 h after i.n. delivery of CFSE-labeled apoptotic
BALB/c thymocytes, human neutrophils, or murine lung epithelial cells
(MLE 12). Fig. S2 demonstrates that splenic CD8+ DCs do not migrate
down afferent lymphatics. Table S1, included as a separate PDF file, shows
gene expression analysis for candidate phosphatidylserine receptors, bridging
molecules, Toll-like receptors, and chemokine receptors for pulmonary DCs,
pulmonary macrophages, and splenic CD4 T cells. Table S2, included as a
separate PDF file, validates gene array for known protein expression associated with pulmonary DCs, splenic DCs, pulmonary macrophages, and splenic
CD4 T cells. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20110538/DC1.
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